tiprankstipranks
Trxade Group (MEDS)
NASDAQ:MEDS

Trxade Group (MEDS) Income Statement

135 Followers

Trxade Group Income Statement

Last quarter (Q3 2023), Trxade Group's total revenue was $2.06M, a decrease of -14.26% from the same quarter last year. In Q3, Trxade Group's net income was $-3.53M. See Trxade Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 9.09M$ 11.45M$ 9.89M$ 17.12M$ 7.44M$ 3.83M
Cost of Revenue
$ -717.22K$ 6.00M$ 5.14M$ 11.42M$ 2.57M$ 449.05K
Gross Profit
$ 6.45M$ 5.45M$ 4.75M$ 5.71M$ 4.87M$ 3.38M
Operating Expense
$ -852.60K$ 9.88M$ 9.34M$ 7.49M$ 4.38M$ 3.47M
Operating Income
$ 2.05M$ -4.42M$ -4.59M$ -1.78M$ 493.74K$ -87.62K
Net Non Operating Interest Income Expense
$ 336.66K$ -336.21K$ -23.59K$ -29.39K$ -53.23K$ -57.54K
Other Income Expense
$ 1.30M$ -58.13K$ -247.86K$ -725.97K$ -724.95K$ 154.19K
Pretax Income
$ 2.77M$ 162.34K$ -5.32M$ -2.54M$ -284.43K$ 9.04K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -1.76M$ -925.19K$ -5.32M$ -2.54M$ -284.43K$ 9.04K
Basic EPS
$ -15.18$ -0.41$ -0.65$ -0.33$ -0.05$ <0.01
Diluted EPS
$ -9.02$ -0.41$ -0.65$ -0.33$ -0.05$ <0.01
Basic Average Shares
$ 19.99M$ 8.47M$ 8.14M$ 7.71M$ 5.93M$ 5.38M
Diluted Average Shares
$ 13.11M$ 8.47M$ 8.14M$ 7.71M$ 5.93M$ 5.83M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -1.57M$ 15.87M$ 14.48M$ 18.90M$ 6.94M$ 3.92M
Net Income From Continuing And Discontinued Operation
$ -7.36M$ -925.19K$ -5.32M$ -2.54M$ -284.43K$ 9.04K
Normalized Income
$ -669.33K$ 2.29M-$ -1.81M$ 512.59K$ 14.47K
Interest Expense
---$ 29.39K$ 53.23K$ 57.54K
EBIT
$ 2.44M$ 498.55K$ -5.29M$ -2.51M$ -231.20K$ 66.58K
EBITDA
$ 3.65M$ 694.40K$ -5.15M$ -2.40M$ -136.47K$ 66.58K
Currency in USD

Trxade Group Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis